Chronic low back pain, bacterial infection and treatment with antibiotics
- PMID: 33610802
- DOI: 10.1016/j.spinee.2021.02.013
Chronic low back pain, bacterial infection and treatment with antibiotics
Abstract
The contribution of bacterial infection to chronic low back pain and its treatment with antibiotics have generated considerable controversy in literature. If efficacious, antibiotics have the potential to transform the treatment of chronic low back pain in a significant subset of patients. Some microbiology studies of disc tissue from patients with CLBP have shown that bacteria are present, most likely due to infection, while others conclude they are absent or if found, it is due to surgical contamination. Clinical studies testing the efficacy of oral antibiotics to treat CLBP have either shown that the treatment is efficacious leading to significantly reduced pain and disability or that their effect is modest and not clinically significant. Critical review of the literature on CLBP, bacterial infection and treatment with antibiotics identified five well-designed and executed microbiology studies characterizing bacteria in disc samples that demonstrate that bacteria do infect herniated disc tissue, but that the bacterial burden is low and may be below the limits of detection in some studies. Two randomized, controlled clinical trials evaluating oral antibiotics in patients with CLBP indicate that for certain subsets of patients, the reduction in pain and disability achieved with antibiotic therapy may be significant. In patients for whom other therapies have failed, and who might otherwise progress to disc replacement or fusion surgery, antibiotic therapy may well be an attractive option to reduce the individual suffering associated with this debilitating condition. Additional clinical research is recommended to refine the selection of patients with CLBP caused or complicated by bacterial infection and most likely to respond to antibiotics, to optimize antibiotic therapy to maximize patient benefit, to minimize and manage side effects, and to address legitimate concerns about antibiotic stewardship.
Keywords: Antibiotic; Chronic low back pain; Cutibacterium acnes; Infection; Modic changes.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Comment in
-
Letter to the Editor regarding, "Chronic low back pain, bacterial infection, and treatment with antibiotics".Spine J. 2021 Jul;21(7):1229-1230. doi: 10.1016/j.spinee.2021.03.034. Spine J. 2021. PMID: 34243895 No abstract available.
-
Reply to a letter to the editor regarding "Chronic low back pain, bacterial infection and treatment with antibiotics".Spine J. 2021 Jul;21(7):1231-1232. doi: 10.1016/j.spinee.2021.03.036. Spine J. 2021. PMID: 34243896 No abstract available.
-
Letter to the editor concerning "Comment to chronic low back pain, bacterial infection and treatment with antibiotics".Spine J. 2021 Jul;21(7):1233-1235. doi: 10.1016/j.spinee.2021.03.035. Spine J. 2021. PMID: 34243897 No abstract available.
-
Reply to a letter to the editor regarding the article, "Chronic low back pain, bacterial infection and treatment with antibiotics. Gilligan CJ, Cohen SP, Fischetti VA, Hirsch JA, Czaplewski LG. Spine J 2021 Feb 18;S1529-9430".Spine J. 2021 Jul;21(7):1236-1237. doi: 10.1016/j.spinee.2021.03.033. Spine J. 2021. PMID: 34243898 No abstract available.
Similar articles
-
Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.Acta Orthop Suppl. 2013 Feb;84(349):1-35. doi: 10.3109/17453674.2012.753565. Acta Orthop Suppl. 2013. PMID: 23427903
-
Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy.Eur Spine J. 2013 Apr;22(4):697-707. doi: 10.1007/s00586-013-2675-y. Epub 2013 Feb 13. Eur Spine J. 2013. PMID: 23404353 Free PMC article. Clinical Trial.
-
Antibiotic treatment In patients with chronic low back pain and Modic changes (the AIM study): study protocol for a randomised controlled trial.Trials. 2017 Dec 15;18(1):596. doi: 10.1186/s13063-017-2306-8. Trials. 2017. PMID: 29246188 Free PMC article. Clinical Trial.
-
What Is the Role of the Bacterium Propionibacterium acnes in Type 1 Modic Changes? A Review of the Literature.Can Assoc Radiol J. 2017 Nov;68(4):419-424. doi: 10.1016/j.carj.2017.07.004. Epub 2017 Oct 3. Can Assoc Radiol J. 2017. PMID: 28985974 Review.
-
[Antibiotics should not be used for treating back pain due to Modic changes].Ugeskr Laeger. 2020 Oct 12;182(42):V06200476. Ugeskr Laeger. 2020. PMID: 33046199 Review. Danish.
Cited by
-
Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms.Korean J Pain. 2023 Jul 1;36(3):281-298. doi: 10.3344/kjp.23129. Korean J Pain. 2023. PMID: 37394272 Free PMC article. Review.
-
Preclinical development and characterisation of PP353, a formulation of linezolid for intradiscal administration.JOR Spine. 2024 Nov 14;7(4):e70010. doi: 10.1002/jsp2.70010. eCollection 2024 Dec. JOR Spine. 2024. PMID: 39544355 Free PMC article.
-
Chronic pain and infection: mechanisms, causes, conditions, treatments, and controversies.BMJ Med. 2022 Mar 31;1(1):e000108. doi: 10.1136/bmjmed-2021-000108. eCollection 2022. BMJ Med. 2022. PMID: 36936554 Free PMC article. Review.
-
Immuno-Modulatory Effects of Intervertebral Disc Cells.Front Cell Dev Biol. 2022 Jun 29;10:924692. doi: 10.3389/fcell.2022.924692. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35846355 Free PMC article. Review.
-
Modic change is associated with increased BMI but not autoimmune diseases in TwinsUK.Eur Spine J. 2023 Oct;32(10):3379-3386. doi: 10.1007/s00586-023-07870-7. Epub 2023 Aug 9. Eur Spine J. 2023. PMID: 37555954
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical